Prothena Corporation plc (NASDAQ: PRTA) on Tuesday, plunged -30.40% from the previous trading day, before settling in for the closing price of $6.58. Within the past 52 weeks, PRTA’s price has moved between $6.36 and $25.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 4692.68% over the last five years. The company achieved an average annual earnings per share of -60.06%. With a float of $42.32 million, this company’s outstanding shares have now reached $53.83 million.
The firm has a total of 163 workers. Let’s measure their productivity. In terms of profitability, gross margin is 57.64%, operating margin of -100.49%, and the pretax margin is -84.0%.
Prothena Corporation plc (PRTA) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Prothena Corporation plc is 21.38%, while institutional ownership is 83.92%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -60.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.31% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Prothena Corporation plc (PRTA) is currently performing well based on its current performance indicators. A quick ratio of 9.00 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -1.01 in the next quarter and is forecasted to reach -3.24 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Analysing the last 5-days average volume posted by the [Prothena Corporation plc, PRTA], we can find that recorded value of 2.95 million was better than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 11.86%. Additionally, its Average True Range was 0.73.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 1.10%, which indicates a significant decrease from 3.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 157.61% in the past 14 days, which was higher than the 84.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.69, while its 200-day Moving Average is $14.87. Now, the first resistance to watch is $5.14. This is followed by the second major resistance level at $5.70. The third major resistance level sits at $6.04. If the price goes on to break the first support level at $4.23, it is likely to go to the next support level at $3.89. Should the price break the second support level, the third support level stands at $3.33.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
Market capitalization of the company is 246.53 million based on 53,827K outstanding shares. Right now, sales total 135,160 K and income totals -122,310 K. The company made 2,830 K in profit during its latest quarter, and -60,200 K in sales during its previous quarter.
